Instinct Bio Technical Company Holdings Inc

Instinct Bio Technical Company Holdings Inc (BIOT) Stock Analysis

$0.228

-0.039 (-17.16%)At close

Loading chart…
High
0.307
Open
0.283
VWAP
0.25
Volume
1.05M
Mkt Cap
—
Low
0.227
Amount
267.15K
EV/EBITDA, TTM
0.00

Instinct Bio Technical Company Holdings Inc. is a vertically integrated biotechnology holding company that works in stem cell and regenerative medicine-related fields, wellness and beauty. It operates through subsidiaries. The core activities include research and development in regenerative stem cell cosmetics that focus on regenerative stem cell technology for advanced skincare and personal care formulations, raw materials and supply chain management including procurement, distribution and logistics of raw materials essential for stem cell-conditioned media, original equipment manufacturer and original design manufacturer (OEM/ODM) cosmetic products provision, brand franchising, branding and creative design solutions provision, influencer and celebrity brand collaborations and e-commerce platforms operation. Its product categories include skincare, body and hair care, inner care and supplements, and professional line. Its brands include MANOROL, HAKUA, VIVEA, GENREVER and others.

AI analysis of Instinct Bio Technical Company Holdings Inc (BIOT)

Sell

Given the current price of $0.23 and an RSI of 9.446, which indicates extreme oversold conditions, this asset is not a good buy right now due to significant downward momentum and lack of positive catalysts.

Valuation Metrics

The current forward P/E ratio for Instinct Bio Technical Company Holdings Inc (BIOT) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

BIOT FAQ — answered by Alphio AI

Instinct Bio Technical Company Holdings Inc. is a vertically integrated biotechnology holding company that works in stem cell and regenerative medicine-related fields, wellness and beauty. It operates through subsidiaries. The core activities include research and development in regenerative stem cell cosmetics that focus on regenerative stem cell technology for advanced skincare and personal care formulations, raw materials and supply chain management including procurement, distribution and logistics of raw materials essential for stem cell-conditioned media, original equipment manufacturer and original design manufacturer (OEM/ODM) cosmetic products provision, brand franchising, branding and creative design solutions provision, influencer and celebrity brand collaborations and e-commerce platforms operation. Its product categories include skincare, body and hair care, inner care and supplements, and professional line. Its brands include MANOROL, HAKUA, VIVEA, GENREVER and others. It operates in the Consumer Non-Cyclicals sector.

Given the current price of $0.23 and an RSI of 9.446, which indicates extreme oversold conditions, this asset is not a good buy right now due to significant downward momentum and lack of positive catalysts.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading